Psychiatry Expert Perspectives in Tardive Dyskinesia to Cover Key Topics in Tardive Dyskinesia Treatment expert perspectives By Andrew J. Cutler, MD; Leslie Citrome, MD, MPH; Rakesh Jain, MD, MPH
Uncategorized Predicting Progression of Lower-Risk MDS expert roundtables By Andrew M. Brunner, MD; Courtney D. DiNardo, MD, MSCE; Rami S. Komrokji, MD
Uncategorized Perspectives on Newly Diagnosed MDS expert roundtables By Andrew M. Brunner, MD; Courtney D. DiNardo, MD, MSCE; Rami S. Komrokji, MD
Uncategorized Evaluating Combined TIM-3 Inhibition and Hypomethylating Agent Therapy in High-Risk MDS and AML clinical topic updates By Andrew M. Brunner, MD
Uncategorized Hypomethylating Agent Resistance in High-Risk MDS clinical topic updates By Rami S. Komrokji, MD